Now accepting Telehealth appointments. Schedule a virtual visit.

The Safety and Concerns with Transcranial Magnetic Stimulation (TMS)

Transcranial Magnetic Stimulation is well known to be an effective treatment for Depresesion as well as other health issues including anxiety and OCD. This is a widely used option after multiple medications have not been effective. This therapy is usually well tolerated by patients and causes very few side effects. The stimulation targets a very localized spot of about a two centimeter diameter on the surface of the head, usually the Dorsal Lateral Prefrontal Cortex (DLPFC) since it is the region where mood and cognitive control is mostly located. This research paper explains effects of targeting the Left DLPFC. 

In comparison to medications, TMS does not introduce any foreign synthetic molecules into the body which disrupts many cellular processes and can lead to various side effects depending on each patient. TMS therapy allows a patient to fully awake during the entirety of the treatment and does not require any sedation. After the session is over, patients can go about their day regularly. TMS is a safer and less invasive alternative to other brain stimulation procedures such as Electroconvulsive Therapy (ECT) and Vagus Nerve Stimulation.  

Common TMS Side Effects:


Call us today to schedule an appointment to see if TMS is right for you. 

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).